New bunion surgery aims for faster recovery, but study halted early
NCT ID NCT05082012
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a new surgical procedure called Lapiplasty Mini-Incision for treating bunions (hallux valgus) in people aged 14 to 58. The goal was to see if it could correct the deformity and allow patients to walk sooner after surgery. However, the study was terminated early, so we don't have complete results on how well it worked or its long-term safety.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Lapiplasty Mini-Incision surgical procedure
- What this could lead to
- If successful, this could offer a less invasive bunion surgery with quicker return to walking.
- What could go wrong
- The study was terminated early, so we don't have full data on safety or effectiveness. It's also a surgical device study, not a drug trial.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
123 people
The number who actually took part.
- Started
-
Sep 2021
- Finished
-
May 2024
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
14 to 58 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: Patients satisfying the following criteria will be considered the screening population and will be eligible for participation: 1. Male and females between the ages 14 and 58 years at the time of consent; 2. Closed physeal plates at the time of consent; 3. Intermetatarsal angle is between 10.0˚ - 22.0˚; 4. Hallux valgus angle is between 16.0˚ - 40.0˚; 5. Willing and able to adhere to early weight-bearing instructions post-operatively; 6. Capable of completing self-administered questionnaires; 7. Acceptable surgical candidate, including use of general anesthesia; 8. Female patients must be of non-child bearing potential or have a negative pregnancy test within 7 days prior to index procedure; 9. Willing and able to schedule index procedure within 3 months of consent and able to return for scheduled follow-up visits; 10. Willing and able to provide written informed consent. Exclusion Criteria: Patients satisfying the following criteria will not be eligible for participation: 1. Previous surgery for hallux valgus on operative side; 2. Previous surgeries on operative foot involving fusion of foot or ankle joints (other than hammertoe or lesser toes/digits); 3. Additional concomitant procedures outside of the 1st ray; 4. Moderate or Severe osteoarthritis of the MTP joint based on radiographic imaging (including lack of evident crista) or positive grind test; 5. Symptomatic flatfoot or asymptomatic flatfoot (defined as calcaneal inclination \<5˚and talonavicular subluxation/uncovering \>50%); 6. BMI \>40 kg/m²; 7. Current nicotine user, including current use of nicotine patch; 8. Current clinical diagnosis of diabetes with fasting plasma glucose \> 126 mg/dL and/or HbA1c ≥7.0; 9. Current clinical diagnosis of peripheral neuropathy or by assessment on 4-point monofilament test; 10. Current clinical diagnosis of fibromyalgia; 11. Current clinical diagnosis of Complex Regional Pain Syndrome/Reflex Sympathetic Dystrophy (CRPS/RSD); 12. Current uncontrolled hypothyroidism; 13. Previously sensitized to titanium; 14. Currently taking oral steroids or rheumatoid biologics; 15. Currently taking immunosuppressant drugs; 16. Insufficient quantity or quality of bone to permit stabilization, conditions that retard healing (not including pathological fractures) and conditions causing poor blood supply such as peripheral vascular disease; 17. Active, suspected or latent infection in the affected area; 18. Use of synthetic or allogenic bone graft substitutes; 19. Current diagnosis of metatarsus adductus (defined as MAA ≥ 23˚); 20. Known keloid and hypertrophic scar forming; 21. Scheduled to undergo a same-day bilateral procedure. Patient agrees to refrain from the Lapiplasty® Procedure (or other hallux valgus procedures) on contralateral foot for minimum of 6 months post index procedure; 22. Patient has previously been enrolled into this study for a contralateral procedure; 23. Scheduled for any concomitant procedure that would alter patient's ability to early weight-bear post-procedure; 24. Patient requires an incision \>4.0 cm to complete the procedure (determined pre-operatively or intra-operatively); 25. Patient is actively involved with a workman's compensation case or is currently involved in litigation; 26. Patient is currently or has participated in a clinical study in the last 30 days prior to signing informed consent or is considering participation in another research protocol during this study. Exceptions to this include survey clinical studies with no treatment or if subject is greater than 12 months post procedure in the Treace ALIGN3D™ study without ongoing protocol defined AE; these are not exclusionary; 27. Patient has a condition or finding that, in the opinion of the Investigator, may jeopardize the patient's well-being, the soundness of this clinical study, or could interfere with provision of informed consent, completion of tests, therapy, or follow-up.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Bunion are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
DOC - Decatur Orthopaedic Clinic
Decatur, Alabama, 35601, United States
-
DOC - Decatur Orthopaedic Clinic
Hartselle, Alabama, 35640, United States
-
Desert Orthopaedic Center
Las Vegas, Nevada, 89121, United States
-
Foot & Ankle Associates of North Texas - Keller
Keller, Texas, 76248, United States
-
JCMG - Podiatry
Jefferson City, Missouri, 65109, United States
-
Orlando Foot and Ankle Clinic - Waterford Lakes Office
Orlando, Florida, 32825, United States
-
Phoenix Foot and Ankle Institute
Scottsdale, Arizona, 85251, United States
-
Sports Medicine Associates of San Antonio
San Antonio, Texas, 78240, United States
-
Stonebriar Foot and Ankle
Frisco, Texas, 75034, United States
-
University of Pennsylvania / Penn Medicine
Philadelphia, Pennsylvania, 19106, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could bunion surgery patients walk right away? trial puts it to the test
- Can an extra surgical step make bunion correction last longer?
- Can custom foot inserts ease bunion pain? a trial puts them to the test
- Will a bunion fix make your shoes fit better? 3D scans aim to find out
- Can a smartphone app help feet heal faster after bunion surgery?
- Bunion surgery showdown: to screw or not to screw?